Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories

Brain Research Bulletin

Volumn 87, Issue 6, 2012, Pages 556-563

  Sui, Li ^a   Chen, Meng ^b  

^a UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Autism; Fear memory; In vivo; Medial prefrontal cortex (mPFC); Synaptic plasticity; Valproic acid

Indexed keywords

VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; CONDITIONING; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FACILITATION; FEAR; FEAR MEMORY; FEMALE; LONG TERM MEMORY; LONG TERM POTENTIATION; MEDIAL PREFRONTAL CORTEX; NERVE CELL PLASTICITY; NONHUMAN; PAIRED PULSE FACILITATION; PREFRONTAL CORTEX; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SYNAPTIC TRANSMISSION;

ANALYSIS OF VARIANCE; ANIMALS; BIOPHYSICS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; FEAR; FEMALE; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RETENTION (PSYCHOLOGY); SYNAPTIC TRANSMISSION; TIME FACTORS; VALPROIC ACID;

EID: 84862810515     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.01.011     Document Type: Article

References (43)

1. Alsdorf R., Wyszynski D.F. Teratogenicity of sodium valproate. Expert Opin. Drug Saf. 2005, 4:345-353.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC, pp. 66-71. 4th ed.
3. Arndt T.L., Stodgell C.J., Rodier P.M. The teratology of autism. Int. J. Dev. Neurosci. 2005, 23:189-199.
4. Baron-Cohen S., Ring H.A., Wheelwright S., Bullmore E.T., Brammer M.J., Simmons A., Williams S.C. Social intelligence in the normal and autistic brain: an fMRI study. Eur. J. Neurosci. 1999, 11:1891-1898.
5. Binkerd P.E., Rowland J.M., Nau H., Hendrickx A.G. Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. Fundam. Appl. Toxicol. 1988, 11:485-493.
6. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
7. Castelli F., Frith C., Happé F., Frith U. Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain 2002, 125:1839-1849.
8. D'Hooge R., Lüllmann-Rauch R., Beckers T., Balschun D., Schwake M., Reiss K., von Figura K., Saftig P. Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis. J. Neurosci. 2005, 25:6539-6549.
9. Gaffney G.R., Kuperman S., Tsai L.Y., Minchin S. Morphological evidence for brainstem involvement in infantile autism. Biol. Psychiatry 1988, 24:578-586.
10. Gemmell C., O'Mara S.M. Long-term potentiation and paired-pulse facilitation in the prelimbic cortex of the rat following stimulation in the contralateral hemisphere in vivo. Exp. Brain Res. 2000, 132:223-229.
11. Gilbert S.J., Meuwese J.D., Towgood K.J., Frith C.D., Burgess P.W. Abnormal functional specialization within medial prefrontal cortex in high-functioning autism: a multi-voxel similarity analysis. Brain 2009, 132:869-878.
12. Gilmartin M.R., Helmstetter F.J. Trace and contextual fear conditioning require neural activity and NMDA receptor-dependent transmission in the medial prefrontal cortex. Learn. Mem. 2010, 17:289-296.
13. Gordon A.G. Alcohol, deafness, epilepsy, and autism. Alcohol. Clin. Exp. Res. 1993, 17:926-928.
14. Happé F., Frith U. The neuropsychology of autism. Brain 1996, 119:1377-1400.
15. Hashimoto T., Tayama M., Murakawa K., Yoshimoto T., Miyazaki M., Harada M., Kuroda Y. Development of the brainstem and cerebellum in autistic patients. J. Autism Dev. Disord. 1995, 25:1-18.
16. Heidbreder C.A., Groenewegen H.J. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci. Biobehav. Rev. 2003, 27:555-579.
17. Ingram J.L., Peckham S.M., Tisdale B., Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 2000, 22:319-324.
18. Jeffery K. LTP and spatial learning-where to next?. Hippocampus 1997, 7:95-110.
19. Kennedy D.P., Redcay E., Courchesne E. Failing to deactivate: resting functional abnormalities in autism. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8275-8280.
20. Krueger F., Barbey A.K., Grafman J. The medial prefrontal cortex mediates social event knowledge. Trends Cogn. Sci. 2009, 13:103-109.
21. Markram K., Rinaldi T., La Mendola D., Sandi C., Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008, 33:901-912.
22. Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?. Reprod. Toxicol. 2009, 28:1-10.
23. Pavlov I.P. Conditioned Reflexes: An Investigation of the Physiological Activity of the Cerebral Cortex 1927, Oxford University Press, London, UK.
24. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, New York. 2nd ed.
25. Penn H.E. Neurobiological correlates of autism: a review of recent research. Child Neuropsychol. 2006, 12:57-79.
26. Persico A.M., Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006, 29:349-358.
27. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 1992, 106:274-285.
28. Pierce K., Haist F., Sedaghat F., Courchesne E. The brain response to personally familiar faces in autism: findings of fusiform activity and beyond. Brain 2004, 127:2703-2716.
29. Rinaldi T., Perrodin C., Markram H. Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front. Neural Circuits 2008, 2:4.
30. Rinaldi T., Kulangara K., Antoniello K., Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13501-13506.
31. Roder S., Danober L., Pozza M.F., Lingenhoehl K., Wiederhold K.H., Olpe H.R. Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice. Neuroscience 2003, 120:705-720.
32. Rodier P.M., Ingram J.L., Tisdale B., Croog V.J. Linking etiologies in humans and animal models: studies of autism. Reprod. Toxicol. 1997, 11:417-422.
33. Rodier P.M., Ingram J.L., Tisdale B., Nelson S., Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 1996, 370:247-261.
34. Runyan J.D., Dash P.K. Intra-medial prefrontal administration of SCH-23390 attenuates ERK phosphorylation and long-term memory for trace fear conditioning in rats. Neurobiol. Learn. Mem. 2004, 82:65-70.
35. Runyan J.D., Moore A.N., Dash P.K. A role for prefrontal cortex in memory storage for trace fear conditioning. J. Neurosci. 2004, 24:1288-1295.
36. Schneider T., Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005, 30:80-89.
37. Schneider T., Labuz D., Przewłocki R. Nociceptive changes in rats after prenatal exposure to valproic acid. Pol. J. Pharmacol. 2001, 53:531-534.
38. Sheng M., Kim M.J. Postsynaptic signaling and plasticity mechanisms. Science 2002, 298:776-780.
39. South M., Larson M.J., White S.E., Dana J., Crowley M.J. Better fear conditioning is associated with reduced symptom severity in autism spectrum disorders. Autism Res. 2011, 4:412-421.
40. Stanton M.E., Peloso E., Brown K.L., Rodier P. Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism. Behav. Brain Res. 2007, 176:133-140.
41. Strömland K., Nordin V., Miller M., Akerström B., Gillberg C. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 1994, 36:351-356.
42. Sui L., Wang J., Li B.M. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn. Mem. 2008, 15:762-776.
43. Wang Y., Markram H., Goodman P.H., Berger T.K., Ma J., Goldman-Rakic P.S. Heterogeneity in the pyramidal network of the medial prefrontal cortex. Nat. Neurosci. 2006, 9:534-542.